Cargando…

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer

BACKGROUND: TP53 gene mutation is one of the most common mutations in human bladder cancer (BC) and has been implicated in the progression and prognosis of BC. METHODS: RNA sequencing data and TP53 mutation data in different populations and platforms were downloaded from The Cancer Genome Atlas (TCG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiangkun, Lv, Daojun, Cai, Chao, Zhao, Zhijian, Wang, Ming, Chen, Wenzhe, Liu, Yongda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774015/ https://www.ncbi.nlm.nih.gov/pubmed/33391264 http://dx.doi.org/10.3389/fimmu.2020.590618

Ejemplares similares

Identification of a Novel Signature and Construction of a Nomogram Predicting Overall Survival in Clear Cell Renal Cell Carcinoma
por: Wu, Xiangkun, et al.
Publicado: (2020)

A TP53-based immune prognostic model for muscle-invasive bladder cancer
por: Li, Hongyan, et al.
Publicado: (2020)

Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer
por: Lv, Daojun, et al.
Publicado: (2021)

A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7
por: Wu, Xiangkun, et al.
Publicado: (2020)

Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature
por: Liu, Hua-Ping, et al.
Publicado: (2023)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

Cause-specific mortality of low and selective intermediate-risk prostate cancer patients with active surveillance or watchful waiting
por: Wu, Xiangkun, et al.
Publicado: (2021)

Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma
por: Lv, Daojun, et al.
Publicado: (2021)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
por: Zhou, Yi, et al.
Publicado: (2023)

Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer
por: He, Yang, et al.
Publicado: (2021)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2018)

A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients
por: Wu, Xiangkun, et al.
Publicado: (2020)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer
por: He, Yang, et al.
Publicado: (2022)

Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer
por: Jiang, Mengping, et al.
Publicado: (2022)

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer
por: Abudurexiti, MierXiati, et al.
Publicado: (2019)

A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer
por: Sheng, Haoyue, et al.
Publicado: (2021)

Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients
por: Tang, Huamei, et al.
Publicado: (2020)

Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer
por: De Carlo, Camilla, et al.
Publicado: (2022)

A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma
por: Zhang, Xiaonan, et al.
Publicado: (2022)

A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer
por: Liu, Xun, et al.
Publicado: (2021)

NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer
por: Wu, Junlong, et al.
Publicado: (2017)

TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarker
por: Ge, Xinqi, et al.
Publicado: (2022)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

CD8(+) T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma
por: Wu, Xiangkun, et al.
Publicado: (2021)

Does Radical Cystectomy Improve Overall Survival in Octogenarians with Muscle-Invasive Bladder Cancer?
por: Yoo, Sangjun, et al.
Publicado: (2011)

Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy
por: Pan, Yi-Hui, et al.
Publicado: (2021)

A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer
por: Fu, Yang, et al.
Publicado: (2021)

Coexistence of YWHAZ amplification predicts better prognosis in muscle-invasive bladder cancer with CDKN2A or TP53 loss
por: Liu, Shenghua, et al.
Publicado: (2016)

Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status
por: Dueñas, Marta, et al.
Publicado: (2019)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of TP53
por: Ashby, Cody, et al.
Publicado: (2019)

Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival
por: Mundi, Neil, et al.
Publicado: (2019)

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value
por: Lehmann, Brian David, et al.
Publicado: (2015)

The prognostic effect of sixteen malnutrition/inflammation-based indicators on the overall survival of chemotherapy patients
por: Liu, Tong, et al.
Publicado: (2023)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021)

Identification of a six-gene prognostic signature for bladder cancer associated macrophage
por: Jiang, Yunzhong, et al.
Publicado: (2022)

High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients
por: Cho, Sung-Yup, et al.
Publicado: (2017)

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
por: Akahane, Tomoko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gtd2in95nk4la8iag7cun66ku8